Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning

Metformin is a first-line drug used for the treatment of type 2 diabetes. Recently, metformin has been reported to reduce the carcinogenic risk and inhibit tumor cell growth in glioma and breast cancer. The anticancer action of metformin involves the enhancement of phosphorylation of liver kinase B1...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: IRIE, HARUKO, BANNO, KOUJI, YANOKURA, MEGUMI, IIDA, MIHO, ADACHI, MASATAKA, NAKAMURA, KANAKO, UMENE, KIYOKO, NOGAMI, YUYA, MASUDA, KENTA, KOBAYASHI, YUSUKE, TOMINAGA, EIICHIRO, AOKI, DAISUKE
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2016
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734273/
https://ncbi.nlm.nih.gov/pubmed/26893732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4075
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi